Ube
4208.TChemicals
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥462.3bn | ¥486.8bn | ¥468.2bn | ¥494.7bn | ¥655.3bn | ¥613.9bn |
| Operating income | ¥18.9bn | ¥18.0bnr | ¥22.5bn | ¥16.2bnr | ¥44.0bn | ¥25.9bn |
| Ordinary income | ¥37.5bn | ¥22.4bnr | ¥36.3bn | −¥8.7bnr | ¥41.5bn | ¥23.3bn |
| Net income (owners) | ¥23.9bn | −¥4.8bn | ¥29.0bn | −¥7.0bnr | ¥24.5bn | ¥22.9bn |
| Total assets | ¥946.3bn | ¥866.2bnr | ¥789.0bn | ¥732.7bnr | ¥838.0bn | ¥769.7bn |
| Net assets / equity | ¥454.9bn | ¥412.3bnr | ¥429.4bn | ¥381.6bnr | ¥394.0bn | ¥380.6bn |
| Operating cash flow | ¥60.0bn | ¥35.8bn | ¥53.0bn | ¥18.1bn | ¥32.7bn | ¥66.1bn |
| EPS (basic) | ¥245.76 | ¥-49.6 | ¥298.59 | ¥-72.54r | ¥249.31 | ¥226.79 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 211 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 73 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 211 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 74 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 212 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 74 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 74 figures · EDINET |
| 2022-04-01 → 2023-03-31 | AnnualAmended | 212 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 73 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 212 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 75 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 75 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 74 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 213 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| High Performance Urethans | ¥46.1bn | −¥548m |
| Machinery | ¥68.1bn | ¥6.2bn |
| Pharmaceutical | ¥20.6bn | −¥1.3bn |
| Polymers And Chemicals | ¥228.4bn | ¥8.2bn |
| Specialty Products | ¥50.9bn | ¥9.8bn |
| Other segments | ¥48.1bn | ¥1.9bn |
| Adjustments & eliminations | — | −¥5.4bn |
| Total | ¥462.3bn | ¥24.3bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.